Divis Laboratories Ltd reported 169.32B in Assets for its fiscal quarter ending in March of 2025.


Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Aurobindo Pharma INR 497.85B 16.91B Mar/2025
Avita Medical AUD 79.71M 8.12M Dec/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
Lupin INR 292.05B 37.23B Mar/2025
Moderna USD 12.01B 694M Jun/2025
Organon & Co USD 13.5B 344M Jun/2025
Revvity USD 12.36B 2.06M Jun/2025
Tectonic Therapeutic USD 295.31M 142.4M Jun/2025
Tilray USD 4.19B 70.11M Nov/2024
Viatris USD 38.41B 63.4M Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025